FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and concerns a therapeutic agent for mesothelioma. Substance of the invention involves a mesothelioma cell growth inhibitor containing IL-6-receptor (IL-6R) antibody as an active ingredient.
EFFECT: enabled inhibition of mesothelioma cells by IL-6-receptor (IL-6R) antibodies.
12 cl, 18 ex, 17 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| THERAPEUTIC AGENT FOR MESOTHELIOMA | 2004 |
|
RU2554942C2 |
| PROPHYLACTIC DRUG FOR VASCULITIS | 2004 |
|
RU2379054C2 |
| METHOD OF TREATING INTERLEUKIN-6-DEPENDENT DISEASES | 2004 |
|
RU2509574C2 |
| AGENT FOR CARDIOPATHY | 2006 |
|
RU2450830C2 |
| DRUGS AGAINST CHRONIC RHEUMATIC ARTHRITIS CONTAINING ANTAGONIST OF IL-6 AS EFFECTIVE COMPONENT | 1995 |
|
RU2147443C1 |
| THERAPEUTIC AGENT FOR TREATING DISEASES RELATED TO JUVENILE CHRONIC ARTHRITIS | 2002 |
|
RU2541165C2 |
| THERAPEUTIC AGENT IN SPINAL MARROW INJURY CONTAINING INTERLEUKINE-6 ANTAGONIST | 2004 |
|
RU2358761C2 |
| AGENTS FOR SUPPRESSING TRANSPLANTED ISLAND DAMAGE FOLLOWING ISLAND TRANSPLANTATION | 2006 |
|
RU2446826C2 |
| THERAPEUTIC AGENT USED FOR GRAFT-VERSUS-HOST DISEASE, CONTAINING INTERLEUKIN-6 RECEPTOR INHIBITOR AS ACTIVE INGREDIENT | 2008 |
|
RU2490025C2 |
| THERAPEUTIC AGENT FOR DISEASES, RELATED TO CHILDREN'S CHRONIC ARTHRITIC DISEASES | 2002 |
|
RU2361613C2 |
